Nrc Health (NRC) Cash from Financing Activities (2010 - 2026)

Nrc Health has disclosed Cash from Financing Activities across 17 years of filings, most recently posting -$6.9 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$6.9 million, down 28.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.4 million (down 86.92% YoY), and the FY2025 annual result was -$15.8 million, up 5.52% from the prior year.
• Cash from Financing Activities came in at -$6.9 million for Q1 2026 at Nrc Health, down from -$4.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $6.9 million in Q2 2025 to a low of -$24.0 million in Q3 2023.
• The 5-year median for Cash from Financing Activities is -$5.9 million (2023), against an average of -$8.0 million.
• Peak annual rise in Cash from Financing Activities reached 353.52% in 2025, while the deepest fall reached 77723.53% in 2025.
• Nrc Health's Cash from Financing Activities stood at -$9.5 million in 2022, then soared by 46.45% to -$5.1 million in 2023, then surged by 77.25% to -$1.2 million in 2024, then slumped by 255.8% to -$4.1 million in 2025, then slumped by 67.67% to -$6.9 million in 2026.
• The last three Cash from Financing Activities figures came in at -$6.9 million (Q1 2026), -$4.1 million (Q4 2025), and -$13.2 million (Q3 2025), per Business Quant data.